Cancellations by sponsors

This database shows cancellations of Australian Register of Therapeutic Goods entries requested by sponsors.

Last updated

23 December 2025

Find out more at Information about cancellations requested by the sponsor - regulatory actions.

72580 result(s) found, displaying 14176 to 14200

Wiselink Group Pty Ltd - Nitrile examination/treatment glove, non-powdered Cancelled under Section 41GL(d) of the Act

7 June 2024

Cancellation by sponsor

Requested by Wiselink Group Pty Ltd
Wiselink Group Pty Ltd - Specimen receptacle IVDs Cancelled under Section 41GL(d) of the Act

7 June 2024

Cancellation by sponsor

Requested by Wiselink Group Pty Ltd
Wiselink Group Pty Ltd - Vinyl examination/treatment glove, non-powdered Cancelled under Section 41GL(d) of the Act

7 June 2024

Cancellation by sponsor

Requested by Wiselink Group Pty Ltd
XALOX RTU oxaliplatin 100mg/20mL concentrated solution for injection vial Cancelled under Section 30(1)(c) of the Act

7 June 2024

Cancellation by sponsor

Requested by Medis Pharma Pty Ltd
XALOX RTU oxaliplatin 200mg/40mL concentrated solution for injection vial Cancelled under Section 30(1)(c) of the Act

7 June 2024

Cancellation by sponsor

Requested by Medis Pharma Pty Ltd
XALOX RTU oxaliplatin 50mg/10mL concentrated solution for injection vial Cancelled under Section 30(1)(c) of the Act

7 June 2024

Cancellation by sponsor

Requested by Medis Pharma Pty Ltd
XALOX SOL oxaliplatin 100mg/20mL concentrated solution for injection vial Cancelled under Section 30(1)(c) of the Act

7 June 2024

Cancellation by sponsor

Requested by Medis Pharma Pty Ltd
XALOX SOL oxaliplatin 200mg/40mL concentrated solution for injection vial Cancelled under Section 30(1)(c) of the Act

7 June 2024

Cancellation by sponsor

Requested by Medis Pharma Pty Ltd
XALOX SOL oxaliplatin 50mg/10mL concentrated solution for injection vial Cancelled under Section 30(1)(c) of the Act

7 June 2024

Cancellation by sponsor

Requested by Medis Pharma Pty Ltd
XFactor Plus Cancelled under Section 30(1)(c) of the Act

7 June 2024

Cancellation by sponsor

Requested by Plexus Australia Pty Ltd
ZEIMOPEZIL 10 donepezil hydrochloride 10 mg film coated tablets blister pack Cancelled under Section 30(1)(c) of the Act

7 June 2024

Cancellation by sponsor

Requested by Medis Pharma Pty Ltd
ZEIMOPEZIL 5 donepezil hydrochloride 5 mg film coated tablets blister pack Cancelled under Section 30(1)(c) of the Act

7 June 2024

Cancellation by sponsor

Requested by Medis Pharma Pty Ltd
ZELDOX IM ziprasidone (as mesilate) 20 mg powder for injection vial with diluent Cancelled under Section 30(1)(c) of the Act

7 June 2024

Cancellation by sponsor

Requested by Viatris Pty Ltd
ZELNAFIL 100 sildenafil (as citrate) 100 mg tablet blister pack Cancelled under Section 30(1)(c) of the Act

7 June 2024

Cancellation by sponsor

Requested by Medis Pharma Pty Ltd
ZELNAFIL 25 sildenafil (as citrate) 25 mg tablet blister pack Cancelled under Section 30(1)(c) of the Act

7 June 2024

Cancellation by sponsor

Requested by Medis Pharma Pty Ltd
ZELNAFIL 50 sildenafil (as citrate) 50 mg tablet blister pack Cancelled under Section 30(1)(c) of the Act

7 June 2024

Cancellation by sponsor

Requested by Medis Pharma Pty Ltd
Zi Q Cancelled under Section 30(1)(c) of the Act

7 June 2024

Cancellation by sponsor

Requested by Zifam Pinnacle Pty Ltd
Zinc 50 Cancelled under Section 30(1)(c) of the Act

7 June 2024

Cancellation by sponsor

Requested by Probiomin Pty Ltd
Zinc Immune - Training Advantage Cancelled under Section 30(1)(c) of the Act

7 June 2024

Cancellation by sponsor

Requested by Pillar Performance Pty Ltd
ZIPRASIDONE ACTAVIS ziprasidone (as hydrochloride) 20 mg capsule blister pack Cancelled under Section 30(1)(c) of the Act

7 June 2024

Cancellation by sponsor

Requested by Medis Pharma Pty Ltd
ZIPRASIDONE ACTAVIS ziprasidone (as hydrochloride) 40 mg capsule blister pack Cancelled under Section 30(1)(c) of the Act

7 June 2024

Cancellation by sponsor

Requested by Medis Pharma Pty Ltd
ZIPRASIDONE ACTAVIS ziprasidone (as hydrochloride) 60 mg capsule blister pack Cancelled under Section 30(1)(c) of the Act

7 June 2024

Cancellation by sponsor

Requested by Medis Pharma Pty Ltd
ZIPRASIDONE ACTAVIS ziprasidone (as hydrochloride) 80 mg capsule blister pack Cancelled under Section 30(1)(c) of the Act

7 June 2024

Cancellation by sponsor

Requested by Medis Pharma Pty Ltd
ZIPRASIDONE WT ziprasidone (as hydrochloride) 40 mg capsule blister pack Cancelled under Section 30(1)(c) of the Act

7 June 2024

Cancellation by sponsor

Requested by Medis Pharma Pty Ltd
ZIPRASIDONE-AU ziprasidone (as hydrochloride) 20 mg capsule blister pack Cancelled under Section 30(1)(c) of the Act

7 June 2024

Cancellation by sponsor

Requested by Medis Pharma Pty Ltd

Last updated

23 December 2025

Sub menu

Product regulation

Safety and shortages

Resources and guidance

Business services

Cancellations by sponsors

Filter results

Decision type

Date of effect

Wiselink Group Pty Ltd - Nitrile examination/treatment glove, non-powdered Cancelled under Section 41GL(d) of the Act

Wiselink Group Pty Ltd - Specimen receptacle IVDs Cancelled under Section 41GL(d) of the Act

Wiselink Group Pty Ltd - Vinyl examination/treatment glove, non-powdered Cancelled under Section 41GL(d) of the Act

XALOX RTU oxaliplatin 100mg/20mL concentrated solution for injection vial Cancelled under Section 30(1)(c) of the Act

XALOX RTU oxaliplatin 200mg/40mL concentrated solution for injection vial Cancelled under Section 30(1)(c) of the Act

XALOX RTU oxaliplatin 50mg/10mL concentrated solution for injection vial Cancelled under Section 30(1)(c) of the Act

XALOX SOL oxaliplatin 100mg/20mL concentrated solution for injection vial Cancelled under Section 30(1)(c) of the Act

XALOX SOL oxaliplatin 200mg/40mL concentrated solution for injection vial Cancelled under Section 30(1)(c) of the Act

XALOX SOL oxaliplatin 50mg/10mL concentrated solution for injection vial Cancelled under Section 30(1)(c) of the Act

XFactor Plus Cancelled under Section 30(1)(c) of the Act

ZEIMOPEZIL 10 donepezil hydrochloride 10 mg film coated tablets blister pack Cancelled under Section 30(1)(c) of the Act

ZEIMOPEZIL 5 donepezil hydrochloride 5 mg film coated tablets blister pack Cancelled under Section 30(1)(c) of the Act

ZELDOX IM ziprasidone (as mesilate) 20 mg powder for injection vial with diluent Cancelled under Section 30(1)(c) of the Act

ZELNAFIL 100 sildenafil (as citrate) 100 mg tablet blister pack Cancelled under Section 30(1)(c) of the Act

ZELNAFIL 25 sildenafil (as citrate) 25 mg tablet blister pack Cancelled under Section 30(1)(c) of the Act

ZELNAFIL 50 sildenafil (as citrate) 50 mg tablet blister pack Cancelled under Section 30(1)(c) of the Act

Zi Q Cancelled under Section 30(1)(c) of the Act

Zinc 50 Cancelled under Section 30(1)(c) of the Act

Zinc Immune - Training Advantage Cancelled under Section 30(1)(c) of the Act

ZIPRASIDONE ACTAVIS ziprasidone (as hydrochloride) 20 mg capsule blister pack Cancelled under Section 30(1)(c) of the Act

ZIPRASIDONE ACTAVIS ziprasidone (as hydrochloride) 40 mg capsule blister pack Cancelled under Section 30(1)(c) of the Act

ZIPRASIDONE ACTAVIS ziprasidone (as hydrochloride) 60 mg capsule blister pack Cancelled under Section 30(1)(c) of the Act

ZIPRASIDONE ACTAVIS ziprasidone (as hydrochloride) 80 mg capsule blister pack Cancelled under Section 30(1)(c) of the Act

ZIPRASIDONE WT ziprasidone (as hydrochloride) 40 mg capsule blister pack Cancelled under Section 30(1)(c) of the Act

ZIPRASIDONE-AU ziprasidone (as hydrochloride) 20 mg capsule blister pack Cancelled under Section 30(1)(c) of the Act

Is there anything wrong with this page?